Navigation Links
Thomson Scientific Salutes Nobel Laureate Prize Winners, Many of Whom Were Selected as Thomson Scientific Laureates in 2006
Date:10/16/2007

2007 Winners Demonstrate Strong Correlation Between Citations and

Professional Awards

PHILADELPHIA, and LONDON, Oct. 16 /PRNewswire-FirstCall/ -- Thomson Scientific, part of The Thomson Corporation (NYSE: TOC; TSX: TOC) and leading provider of information solutions to the worldwide research and business communities, accurately predicted two out of four Nobel Prize category winners this year -- in Physiology or Medicine, and in Physics.

This year's Physiology or Medicine award winners Mario R. Capecchi, Sir Martin J Evans, and Oliver Smithies, and the Physics award winners Albert Fert and Peter Grunberg, were accurately forecasted in 2006 as probable Nobel Laureates, using Thomson Scientific's analysis of citations. They were then admitted into the Thomson Scientific Hall of Laureates.

The Nobel Prize winner in Chemistry, although not predicted, is a highly cited scientist and is listed in ISI Highly Cited (http://www.isihighlycited.com/), a freely accessible website that lists individuals that are the most highly cited within various fields for the period 1981-1999.

"Our successful predictions demonstrate the power of citation analysis to reveal important research contributions and the scientists responsible for them," said David Pendlebury, analyst with the Research Services group at Thomson Scientific. "Our prediction method, using citation counts as its fundamental point of departure, has over the years proven to be an accurate measure of research success and of Nobelists to be."

Many studies conducted over the past three decades have shown a strong correlation between citations in the literature and peer esteem, often reflected in professional awards such as the Nobel Prize. Each year, Thomson Scientific adds three candidates per Nobel category to the Thomson Scientific Hall of Laureates. Based on information that includes their citation counts, the selected candidates have a high probability of being awarded the Nobel Prize that year or in future years. Using this method, analysts at Thomson Scientific have successfully predicted 27 Nobel Prize winners since 1989.

Methodology of Predictions

Using Thomson Scientific's Essential Science Indicators, a database for quantitative analysis of performance and trends in global research, and other data from ISI Web of Science, analysts review scientists who typically rank in the top 0.1% in their research areas based on their citation counts and number of high-impact papers.

"Clearly the choices of the Nobel Committees are more complex than simply identifying highly cited or most-cited scientists," said Pendlebury. "We simply use citations as the primary indicator. This tells us where to begin our prediction process."

Each candidate's record is then examined with a thought to discoveries or themes that might be considered worthy of special recognition by the Nobel Committee. In each of four areas -- Physiology or Medicine, Physics, Chemistry, and Economics -- three predictions are made each year and those names added to the elite list of the Thomson Scientific Hall of Laureates. "It's more luck than skill," said Pendlebury. "But by focusing on the most- cited scientists we hope to, as it were, better our luck."

For more information and a list of the Thomson Scientific Laureates, or information on the selection process, please go to: http://scientific.thomson.com/nobel/.

About The Thomson Corporation

The Thomson Corporation (http://www.thomson.com) is a global leader in providing essential electronic workflow solutions to business and professional customers. With operational headquarters in Stamford, Conn., Thomson provides value-added information, software tools and applications to professionals in the fields of law, tax, accounting, financial services, scientific research and healthcare. The Corporation's common shares are listed on the New York and Toronto stock exchanges (NYSE: TOC; TSX: TOC).

Thomson Scientific is a business of The Thomson Corporation. Its information solutions assist professionals at every stage of research and development-from discovery to analysis to product development and distribution. Thomson Scientific information solutions can be found at scientific.thomson.com.


'/>"/>
SOURCE Thomson Scientific
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Jamie Thomson to run California research lab
2. State puts up $1 million for James Thomsons new stem cell startup
3. Thomson lends perspective to stem cell expectations
4. Thomson gives a blueprint of UWs stem cell research
5. UW stem-cell team led by James Thomson gets $1.25M private grant
6. James Thomson plans to stay in Madison to study genesis of stem cells
7. UW-Madisons Beebe wins scientific award
8. Researchers say scientific reporting needs more perspective, less hype
9. Wisconsin stands at the center of scientific efforts to avert flu epidemics
10. Growth prompts new location for scientific instrument manufacturer
11. UW stem cell guru outlines scientific and political future
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... PHILADELPHIA , June 27, 2016  Liquid ... today announced the funding of a Sponsored Research ... study circulating tumor cells (CTCs) from cancer patients.  ... changes in CTC levels correlate with clinical outcomes ... therapies. These data will then be employed to ...
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... the release of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” ... and retention in this eBook by providing practical tips, tools, and strategies for ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
Breaking Biology Technology:
(Date:4/13/2016)... 13, 2016  IMPOWER physicians supporting Medicaid patients in ... new clinical standard in telehealth thanks to a new ... higi platform, IMPOWER patients can routinely track key health ... mass index, and, when they opt in, share them ... to a local retail location at no cost. By ...
(Date:3/29/2016)... 29, 2016 LegacyXChange, Inc. (OTC: ... and SelectaDNA/CSI Protect are pleased to announce our successful ... a variety of writing instruments, ensuring athletes signatures against ... collectibles from athletes on LegacyXChange will be assured of ... DNA. Bill Bollander , CEO states, ...
(Date:3/22/2016)... and SANDY, Utah , ... which operates the highest sample volume laboratory in ... Genomics and UNIConnect, leaders in clinical sequencing informatics and ... launch of a project to establish the informatics infrastructure ... NSO has been contracted by the Ontario ...
Breaking Biology News(10 mins):